AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 61 min read$ARQQ

Ritchie Garth sold $3K of ARQQ

Ritchie Garth sold 121 shares of Arqit Quantum Inc. (ARQQ) at $24.47 across 4 trades on 2026-10-02.

Original reporting
SEC EDGAR · Ritchie Garth
Published Oct 6, 2026, 11:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ARQQ
Neutral
high confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock materially, but it provides transparency for investors monitoring insider activity.

02

Market read

Routine insider sale with minimal market impact.

03

What to watch

No 10b5‑1 plan and the director still holds over 100k shares, indicating continued confidence.

Relevance 3/10Novelty 3/10Timing: post‑market on Oct 2, reported Oct 6

Background

Arqit Quantum Inc. (ARQQ) is a quantum‑technology company listed on NASDAQ. The filing is a standard Form 4 disclosure of an insider transaction.

Company-level read

Ticker impact

$ARQQNeutralHigh confidence
Context

Director Ritchie Garth sold 121 shares for $2,961, a routine Form 4 insider sale disclosed on Oct 6.

Expected impact

likely slight downward pressure as market prices in the small insider sale

Evidence & confidence

The sale is modest ($3K) and does not indicate material concerns, but any insider sell can prompt marginal selling pressure.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

The sale is too small to matter; price may remain unchanged.

Key entities

  • Director
    Ritchie Garth

    Director of Arqit Quantum who sold 121 shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARQQ insider trading history →

Related articles

JUN 4
$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

finance.yahoo.com4 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min